The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Helen McShane

The Jenner Institute

University of Oxford

Oxford

UK

[email]@ndm.ox.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The Jenner Institute, University of Oxford, Oxford, UK. 2009
  • The Jenner Institute, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ. 2009
  • Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK. 2004 - 2005
  • Harrison Clinic, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK. 2005
  • Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. 2001 - 2002

References

  1. Vaccine strategies against tuberculosis. McShane, H. Swiss. Med. Wkly (2009) [Pubmed]
  2. Need for more TB vaccine field sites. McShane, H. Indian J. Exp. Biol. (2009) [Pubmed]
  3. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. McShane, H., Pathan, A.A., Sander, C.R., Goonetilleke, N.P., Fletcher, H.A., Hill, A.V. Tuberculosis. (Edinb) (2005) [Pubmed]
  4. Co-infection with HIV and TB: double trouble. McShane, H. Int. J. STD. AIDS (2005) [Pubmed]
  5. Prime-boost immunisation strategies for tuberculosis. McShane, H., Hill, A. Microbes Infect. (2005) [Pubmed]
  6. Developing an improved vaccine against tuberculosis. McShane, H. Expert. Rev. Vaccines (2004) [Pubmed]
  7. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. McShane, H., Pathan, A.A., Sander, C.R., Keating, S.M., Gilbert, S.C., Huygen, K., Fletcher, H.A., Hill, A.V. Nat. Med. (2004) [Pubmed]
  8. Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A. McShane, H., Behboudi, S., Goonetilleke, N., Brookes, R., Hill, A.V. Infect. Immun. (2002) [Pubmed]
  9. Prime-boost immunization strategies for infectious diseases. McShane, H. Curr. Opin. Mol. Ther. (2002) [Pubmed]
  10. Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. McShane, H., Brookes, R., Gilbert, S.C., Hill, A.V. Infect. Immun. (2001) [Pubmed]
 
WikiGenes - Universities